IDO1 and neoplasm: Moreover, they express immunosuppressive cytokines, consume IL-2, and modulate metabolic interactions at the tumor site by lowering adenosine triphosphate (ATP) levels and inducing IDO expression in the DCs (Ohue and Nishikawa 2019).